The small GTPase Rac has been implicated in a wide range of cellular processes, including the organization of the actin cytoskeleton, transcriptional control and endocytic vesicle trafficking [1-3]. The signaling components that mediate these functions downstream of Rac largely remain to be identified. In this study, we have identified synaptojanin 2, a polyphosphoinositide phosphatase as a novel Rac1 effector. Synaptojanin 2 directly and specifically interacts with Rac1 in a GTPdependent manner. Expression of constitutively active Rac1 caused the translocation of synaptojanin 2 from the cytoplasm to the plasma membrane. Both activated Rac1 and a membrane-targeted version of synaptojanin 2 inhibited endocytosis of the epidermal growth factor (EGF) and transferrin receptors, a process that is known to be dependent on polyphosphoinositide lipids. Endocytosis of growth factor receptors is thought to play an important role in the regulation of cell proliferation. Thus, these results suggest that synaptojanin 2 may mediate the inhibitory effect of Rac1 on endocytosis and could contribute to Rac1-mediated control of cell growth.
Results and discussion

Isolation of a novel Rac1-interacting protein
To isolate novel Rac1 effectors, we screened a HeLa cell cDNA library using the yeast two-hybrid method and activated Rac1 (Rac1V12) as a bait. Two cDNA fragments were obtained that encoded overlapping parts of the carboxy-terminal domain of synaptojanin 2. Synaptojanin 2 is a novel, ubiquitously expressed isoform of synaptojanin 1 [4, 5] , a brain-specific phosphatidylinositol (PI) 5′-phosphatase that has been implicated in synaptic vesicle recycling [6] . To characterize the specificity of the interaction with the carboxy-terminal synaptojanin 2 peptide (termed 2H28, Figure 1d ) obtained from the yeast two-hybrid screen, we tested other Rho-family members that share some binding partners with Rac1. We found that neither Cdc42 nor RhoA interact with 2H28 ( Figure 1a ). Using several deletion constructs, we narrowed down the Rac-binding domain (RBD) of 2H28 to 56 amino acids ( Figure 1a ).
Characterization of human synaptojanin 2 as a Rac1 effector
To determine whether synaptojanin 2 directly binds to Rac1 in a nucleotide-dependent manner, we performed in vitro binding assays. Bacterially expressed glutathione-S-transferase (GST)-2H28-RBD fusion protein directly bound to Rac1 purified from insect cells and preloaded with GTPγS ( Figure 1b) . Some binding to GDP-bound Rac1 could also be detected; however, the affinity for Rac1-GTP, as measured by enzyme-linked immunosorbent assay (ELISA), was 5-10-fold higher than that for GDP (data not shown). No binding to Cdc42-GTP could be detected. To determine whether Rac1 associates with endogenous synaptojanin 2 in vivo, we expressed constitutively activated, Myc-tagged RacL61 or Cdc42L61 in COS-1 cells, immunoprecipitated the GTPases and performed western blot analysis. Endogenous synaptojanin 2 strongly bound to Rac1 but not to Cdc42 (Figure 1c) . Thus, synaptojanin 2 fulfills all the essential criteria to establish it as a bona fide Rac1 effector.
Human synaptojanin 2 is translocated to the plasma membrane by Rac 1
Members of the synaptojanin family contain an amino-terminal Sac1-like inositol polyphosphate phosphatase domain, a central PI 5′-phosphatase domain and a variable carboxy-terminal domain [4, 5] .
As Rac1 binds to the carboxy-terminal domain of synaptojanin 2, we hypothesized that Rac1 may function to translocate synaptojanin 2 to the plasma membrane. To investigate this, we studied the localization of transfected synaptojanin 2 in the presence or absence of co-transfected Rac1V12 in A431 human carcinoma cells. Cells overexpressing synaptojanin 2 alone showed punctate cytoplasmic staining ( Figure 2a) . When co-expressed with Rac1V12, synaptojanin 2 relocalized with Rac1 to the plasma membrane and was clearly visible in membrane ruffles (Figure 2b,c) . A carboxy-terminal truncation mutant of synaptojanin 2, lacking the RBD, was no longer translocated by Rac1 (see Supplementary material), underscoring the importance of the interaction with Rac1 for translocation.
Inhibition of endocytosis by synaptojanin 2
We next addressed the question as to which Rac1-controlled processes are mediated by synaptojanin 2. We focused on two functions that are regulated by Rac and are thought to be modulated by PI metabolism -clathrin-mediated endocytosis and the organization of the actin cytoskeleton [3] . Expression of RacV12 has been shown to inhibit endocytosis of the transferrin receptor in HeLa cells [3] . We have extended these observations, using fluorescently labelled EGF and showed that RacV12 also inhibits endocytosis of the EGF receptor in A431 cells (Figure 3a,b) . To test the role of synaptojanin 2 in clathrin-mediated endocytosis, we reasoned that Rac1 may localize synaptojanin 2 to the plasma membrane and constructed a version of synaptojanin 2 that is constitutively membrane-targeted in a Rac-independent fashion by fusing the central PI 5′-phosphatase domain to the CAAX-motif-containing carboxyl terminus of K-ras. This construct (termed PD-CAAX) localizes to the plasma membrane (Figure 3c ). Overexpression of PD-CAAX efficiently inhibited endocytosis of the EGF receptor (Figure 3d ). Overexpression of synaptojanin 2 alone had no significant effect on endocytosis (data not shown). This is probably due to the fact that overexpressed synaptojanin 2 may not target efficiently to the plasma membrane.
To test whether the inhibitory effect of PD-CAAX depends on its enzymatic activity, we constructed a phosphataseinactive version using site-directed mutagenesis of the two conserved arginines (at positions 796 and 803) in the PI 5′-phosphatase domain [7] . This recombinant protein still targeted to the plasma membrane (Figure 3e ), but no longer inhibited endocytosis (Figure 3f ). The PI 5′-phosphatase domain by itself, without a membrane-targeting sequence, showed a similar cytoplasmic distribution to full-length synaptojanin 2 ( Figure 3g ) and had no effect on endocytosis either (Figure 3h ). Thus, the inhibitory effect of synaptojanin 2 on endocytosis requires its membrane targeting. Identical results were obtained when the effects of these constructs were tested on endocytosis of the transferrin receptor (data not shown). We have also tested whether Rac1 can modulate the lipid phosphatase activity of synaptojanin 2 in vitro, using Rac1 and synaptojanin 2 purified respectively from insect cells and COS cells and PI(3,4,5)P 3 as a substrate, but thus far we have failed to detect any effect of Rac1 on the phosphatase activity of synaptojanin 2 (data not shown).
PI lipids play a prominent role in the regulation of endocytosis. A number of different PI lipids bind the adaptor protein complex AP-2, facilitating its self-assembly, and its interaction with clathrin and peptides that contain endocytic motifs [8] . PIs are also necessary for the activity of the dynamin GTPase, which is essential for vesicle scission from the plasma membrane [9] . Given the strong dependence of the endocytic machinery on PI(4,5)P 2 [10] , a probable mechanism for the inhibitory effect of the membrane-targeted PI 5′-phosphatase is the induction of a decrease in PI(4,5)P 2 levels. We therefore suggest that Rac1 regulates endocytosis at least in part by targeting synaptojanin 2 to the plasma membrane.
Another Rac1-controlled function that is likely to involve PI metabolism is the formation of lamellipodia. Activated Rac is thought to regulate the dynamics of lamellipodia by stimulating actin polymerization at the cell periphery and the activity of a number of actin-binding proteins, including capping and severing proteins, is known to be modulated by PI lipids [11] . To investigate the potential role of synaptojanin 2 in the regulation of actin dynamics, we expressed PD-CAAX in A431 cells and examined its effect on EGF-stimulated lamellipodia formation. At expression levels where PD-CAAX strongly inhibited endocytosis, however, no effect on the formation of lamellipodia could be observed (Figure 4) . Thus, it appears that the integrity of the endocytic machinery may be much more sensitive to a decrease in plasma membrane PI content than lamellipodia formation. In addition, these observations underline the specificity of the inhibitory effect of PD-CAAX on endocytosis.
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Conclusions
We identify the PI phosphatase synaptojanin 2 as a novel Rac1 effector. We show that Rac1 can translocate synaptojanin 2 to the plasma membrane and that a membrane-targeted version of synaptojanin 2 specifically inhibits endocytosis. These results strongly suggest that synaptojanin 2 mediates the inhibitory effect of Rac1 on endocytosis. The endocytosis of growth factor receptors and their subsequent targeting to lysosomes negatively regulates growth factor signaling and inhibition of endocytosis has been shown to enhance cell proliferation [12] . Rac has been implicated in the regulation of cell proliferation [13] and it will therefore be of interest to determine whether synaptojanin 2 mediates the function of Rac1 in this process.
Supplementary material
Supplementary material including methodolgical details and additional figures is available at http://current-biology.com/supmat/supmatin.htm. 
